Is Excessive Electroencephalography Beta Activity Associated with Delinquent Behavior in Men with Attention-Deficit Hyperactivity Disorder Symptomatology?Meier N.M.a, b · Perrig W.a, c · Koenig T.b, c
aDepartment of Psychology, Division of Experimental Psychology and Neuropsychology, bDepartment of Psychiatric Neurophysiology, University Hospital of Psychiatry and cCenter for Cognition, Learning and Memory, University of Bern, Bern, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background/Aims: The attention-deficit/hyperactivity disorder (ADHD) shows an increased prevalence in delinquents compared to the normal population. In recent studies, a subgroup of subjects with ADHD as well as a subgroup of delinquents displayed excessive electroencephalography (EEG) beta activity, which has been associated with antisocial behavior in ADHD children. We investigated whether delinquent behavior in adults with ADHD symptomatology is related to excessive beta activity. Methods: We compared the resting state EEGs (eyes open/closed) of delinquent and nondelinquent subjects with ADHD symptoms and those of a control group regarding EEG power spectra and topography. Results: Delinquents with ADHD symptomatology showed more beta power at frontal, central and parietal brain regions than nondelinquents with ADHD symptoms. Conclusion: Excessive beta power may thus represent a risk factor for delinquent behavior in adults with ADHD symptomatology. The awareness of such a risk factor may be helpful in the assessment of the risk for delinquent behavior in a psychiatric context and may provide a neurobiological background for therapeutic interventions. © 2014 S. Karger AG, Basel
© 2014 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.